Skip to Content

Addendum: Alfuzosin (Uroxatral) -- Another Alpha1-blocker for Benign Prostatic Hyperplasia

Addendum: The table in the article on alfuzosin for treatment of benign prostatic hyperplasia (January 5, 2004, vol. 46, p.1) omitted the generic alpha1-blockers. The complete table with prices updated to December 2003 is now in the issue.


This article has been freely provided.

If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Addendum: Alfuzosin (Uroxatral) -- Another Alpha1-blocker for Benign Prostatic Hyperplasia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1173
Article Code: 1173c
Date: January 5, 2004
Volume: 46
Page: 4

 Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.
 Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.
This article is not available for purchase.